Value
9.1/10data confidence 83%| Component | Sub-score |
|---|---|
| P/E | 8.9 |
| P/S | 9.9 |
| EV/EBITDA | 4.4 |
| Fwd P/E | 10.0 |
| PEG | 10.0 |
- ▸Forward P/E: 5.0x
- ▸PEG: 0.05
- ▸Attractively valued
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
| Pillar | Expectation | Trend |
|---|---|---|
At a forward price-to-earnings multiple of 5.3x and a PEG ratio of 0.05, the stock screens as among the most attractively valued names in the sector—with roughly 21% potential upside to the analyst consensus target against approximately 5.2% downside, a risk/reward ratio of about 4-to-1 in favor. Value | Forward P/E multiple expands above 8x over 12 months as earnings execution improves and the discount to sector peers narrows. | →Stable |
| CounterCheap multiples in this sector often reflect persistent execution concerns that erode the earnings base faster than the multiple can re-rate; three consecutive annual earnings misses averaging roughly 27% below consensus suggest the forward earnings number itself may be too optimistic, making the multiple less attractive than it appears. | ||
After a beat in 2021, the company has delivered three consecutive annual earnings misses with an average shortfall of approximately 27% below consensus—a persistent pattern indicating either structural over-optimism in analyst models, ongoing operational challenges, or both. Earnings | EPS meets or beats consensus in the next reported period (2026-07-29), ending the three-period miss streak and demonstrating that the execution gap is closing. | →Stable |
| CounterAnnual reporting cycles mean only one data point arrives per year; the miss streak spans a period of significant industry disruption, and a single beat in 2026 could catalyze a sharp re-rating if it signals that the structural headwinds have been resolved. | ||
Price is trading below the 200-day moving average, which is declining at roughly 4.0% per month, and a hard death-cross signal—where the short-term moving average has crossed below the long-term—is in effect, representing a severe technical block on any entry regardless of the fundamental value case. Momentum breakdown | The death-cross resolves: the short-term moving average crosses back above the 200-day MA and price holds above the 200-day for 4 consecutive weeks, lifting the technical block. | →Stable |
| CounterDeep-value names with confirmed downtrends can bottom quickly once a fundamental catalyst (an earnings beat, a dividend cut announcement, a debt refinancing) removes the primary bear thesis; waiting for the death-cross to fully resolve may mean missing the initial re-rating move. | ||
Despite earnings misses, free cash flow runs at 214% of net income—significantly above reported earnings—indicating that non-cash charges are substantial and the business generates meaningfully more cash than the income statement reflects, providing a real-cash buffer that the headline miss streak does not capture. Quality | Free cash flow remains above 150% of net income for 2 consecutive reported periods, confirming the elevated cash conversion is structural rather than transitory. | →Stable |
| CounterEven with free cash flow at 214% of net income, the dividend payout ratio stands at 231% of net income—slightly exceeding even the elevated free cash flow—meaning the dividend is marginally consuming more cash than the business generates and cannot be maintained indefinitely without improvement in earnings or a payout reduction. | ||
The dividend payout ratio stands at 231% of net income, consuming materially more than annual earnings—a level that is unsustainable from earnings alone and raises the risk of a dividend reduction that would likely trigger forced selling by income-oriented holders. Catalyst breakdown | Dividend payout ratio falls below 100% of net income within 4 reported periods as earnings recover, removing the sustainability concern. | →Stable |
| CounterFree cash flow running at 214% of net income provides some cushion relative to dividends at 231% of net income; a modest improvement in either operating cash generation or earnings could restore coverage without requiring a formal dividend cut. | ||
CounterCheap multiples in this sector often reflect persistent execution concerns that erode the earnings base faster than the multiple can re-rate; three consecutive annual earnings misses averaging roughly 27% below consensus suggest the forward earnings number itself may be too optimistic, making the multiple less attractive than it appears.
CounterAnnual reporting cycles mean only one data point arrives per year; the miss streak spans a period of significant industry disruption, and a single beat in 2026 could catalyze a sharp re-rating if it signals that the structural headwinds have been resolved.
CounterDeep-value names with confirmed downtrends can bottom quickly once a fundamental catalyst (an earnings beat, a dividend cut announcement, a debt refinancing) removes the primary bear thesis; waiting for the death-cross to fully resolve may mean missing the initial re-rating move.
CounterEven with free cash flow at 214% of net income, the dividend payout ratio stands at 231% of net income—slightly exceeding even the elevated free cash flow—meaning the dividend is marginally consuming more cash than the business generates and cannot be maintained indefinitely without improvement in earnings or a payout reduction.
CounterFree cash flow running at 214% of net income provides some cushion relative to dividends at 231% of net income; a modest improvement in either operating cash generation or earnings could restore coverage without requiring a formal dividend cut.
A biopharmaceutical company trading at a deeply discounted 5.3x forward earnings with a 4-to-1 favorable reward/risk ratio is blocked by a confirmed downtrend including a hard death-cross signal, three consecutive annual earnings misses, a dividend payout ratio at 231% of net income, and financial leverage—creating a value opportunity that cannot be acted on until the price trend and earnings execution reverse.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
| Component | Sub-score |
|---|---|
| P/E | 8.9 |
| P/S | 9.9 |
| EV/EBITDA | 4.4 |
| Fwd P/E | 10.0 |
| PEG | 10.0 |
| Component | Sub-score |
|---|---|
| ROE | 2.0 |
| ROA | 2.8 |
| Gross margin | 3.7 |
| Op margin | 6.6 |
| Net margin | 2.8 |
| Current ratio | 8.4 |
| FCF quality | 10.0 |
| Moat | 3.9 |
| Piotroski F | 7.8 |
| Component | Sub-score |
|---|---|
| Rev growth | 1.3 |
| EPS growth | 10.0 |
| Component | Sub-score |
|---|---|
| RSI | 3.5 |
| MACD | 6.2 |
| OBV | 10.0 |
| MA position | 1.0 |
| Volume | 6.6 |
| Component | Sub-score |
|---|---|
| Analyst rating | 5.0 |
| Price target | 9.5 |
| erm sentiment | 5.0 |
| Component | Sub-score |
|---|---|
| value rank | 9.1 |
| quality rank | 0.3 |
| growth rank | 0.0 |
| Component | Sub-score |
|---|---|
| bollinger | 5.6 |
| support resistance | 5.3 |
| 52w position | 3.3 |
| Component | Sub-score |
|---|---|
| days to cover | 0.1 |
| volatility | 6.6 |
| put call | 10.0 |
| implied vol | 0.0 |
| max pain risk | 3.0 |
| beta | 6.3 |
| debt equity | 4.5 |
| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 0.0 |
| earnings timing | 5.0 |
| surprise avg | 0.0 |
| dividend safety | 7.0 |
Multiple concerning factors. Consider reducing position.
L4:PATH_F_SELLnone
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityAggressive — MCap $4.9B<$5B
The F-path SELL output reflects an overall score of 5.2 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Value at 9.1) was not enough to lift the adjusted overall above the threshold. Current asymmetry R:R is 5.60 — supplementary context, not the trigger for this path.
The strongest dimensions are Value at 9.1, Sentiment at 6.5, and Growth at 5.7; the weakest are Catalyst at 3.4, Peer rank at 3.6, and Risk (lower is worse) at 4.4. The V9 engine cleared all gates with 2 warnings, producing an asymmetric reward-to-risk of 5.60 and an engine sizing output of AVOID.
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
Trip ifForward P/E multiple expands above 8x for 2 consecutive reported periods, indicating the valuation discount has narrowed to a more normal range.
Trip ifEPS beats or meets consensus (surprise above 0%) in the next reported period (2026-07-29), breaking the three-period miss streak.
Trip ifShort-term moving average crosses above the 200-day moving average and price holds above it for 4 consecutive weeks, resolving the death-cross and lifting the technical block.
Trip ifFree cash flow falls below 100% of net income for 2 consecutive reported periods, indicating the cash conversion advantage has deteriorated to a normal level.
Trip ifDividend payout ratio falls below 100% of net income for 2 consecutive reported periods, removing the sustainability concern.